Header

UZH-Logo

Maintenance Infos

Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC)


Seifert, Heike; Georgiou, Alexandros; Alexander, Helen; McLachlan, Jennifer; Bodla, Shankar; Kaye, Stan; Barton, Desmond; Nobbenhuis, Marielle; Gore, Martin; Banerjee, Susana (2015). Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). Gynecologic Oncology, 139(2):216-220.

Statistics

Citations

Dimensions.ai Metrics
8 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 13 Jan 2017
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Oncology
Health Sciences > Obstetrics and Gynecology
Language:German
Date:November 2015
Deposited On:13 Jan 2017 13:17
Last Modified:26 Jan 2022 11:30
Publisher:Elsevier
ISSN:0090-8258
OA Status:Closed
Publisher DOI:https://doi.org/10.1016/j.ygyno.2015.08.015
PubMed ID:26318078